Skip to main content
Top
Published in: Supportive Care in Cancer 7/2019

01-07-2019 | Radiotherapy | Review Article

Prophylactic and therapeutic effects of honey on radiochemotherapy-induced mucositis: a meta-analysis of randomized controlled trials

Authors: Tzu-Ming Liu, Yu-Wei Luo, Ka-Wai Tam, Chia-Chin Lin, Tsai-Wei Huang

Published in: Supportive Care in Cancer | Issue 7/2019

Login to get access

Abstract

Purpose

Oral mucositis is a common side effect of radiochemotherapy and may adversely affect the patients’ quality of life (QoL). Honey application may reduce the mucositis grade in patients. Here, we conducted a meta-analysis of randomized controlled trials (RCTs) to evaluate the prophylactic and therapeutic effects of honey on radiochemotherapy-induced oral mucositis.

Methods

Publications on RCTs were extracted from the PubMed, Embase, CINAHL, and Cochrane Library databases. The primary outcomes were mucositis grades and pain scores. Secondary outcomes were the recovery time and QoL. The study was registered with PROSPERO (number CRD42018108486).

Results

Nineteen RCTs, involving 1276 patients, were reviewed. Honey considerably mitigated oral mucositis in both prophylactic and therapeutic phases. In the prophylactic phase, intolerable mucositis development was significantly prevented in the honey-treated group (RR = 0.18, 95% confidence interval [CI] = 0.09 to 0.41). Patients treated with honey showed significant decrease in pain scores in the first month of treatment (weighted mean difference [WMD] = − 3.25, 95% CI = − 4.41 to − 2.09) and at the end of the treatment (WMD = − 2.32, 95% CI = − 4.47 to − 0.18).

Conclusion

Honey, which is relatively cheap and easily available, prevented mucositis and effectively mitigate mucositis in patients after radiochemotherapy. Moreover, it significantly reduced the mucositis grade and engendered a fast and painless healing process. Therefore, honey use during and after radiochemotherapy is recommended for mucositis prevention and treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Keefe D, Murphy BA (2007) Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy. J Support Oncol 5(9 Suppl 4):13–21 Keefe D, Murphy BA (2007) Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy. J Support Oncol 5(9 Suppl 4):13–21
8.
go back to reference Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1–34.https://doi.org/10.1371/journal.pmed.1000100 Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1–34.https://​doi.​org/​10.​1371/​journal.​pmed.​1000100
10.
go back to reference Al Jaouni SK, Al Muhayawi MS, Hussein A, Elfiki I, Al-Raddadi R, Al Muhayawi SM, Almasaudi S, Kamal MA, Harakeh S (2017) Effects of honey on oral mucositis among pediatric cancer patients undergoing chemo/radiotherapy treatment at King Abdulaziz University Hospital in Jeddah, Kingdom of Saudi Arabia. Evid Based Complement Alternat Med 2017, Article ID 5861024. https://doi.org/10.1155/2017/5861024 Al Jaouni SK, Al Muhayawi MS, Hussein A, Elfiki I, Al-Raddadi R, Al Muhayawi SM, Almasaudi S, Kamal MA, Harakeh S (2017) Effects of honey on oral mucositis among pediatric cancer patients undergoing chemo/radiotherapy treatment at King Abdulaziz University Hospital in Jeddah, Kingdom of Saudi Arabia. Evid Based Complement Alternat Med  2017, Article ID 5861024. https://​doi.​org/​10.​1155/​2017/​5861024
17.
go back to reference Jayalekshmi JL, Lakshmi R, Mukerji A (2016) Honey on oral mucositis: a randomized controlled trial. Gulf J Oncolog 1(20):30–37 Jayalekshmi JL, Lakshmi R, Mukerji A (2016) Honey on oral mucositis: a randomized controlled trial. Gulf J Oncolog 1(20):30–37
19.
go back to reference Khanjani Pour-Fard-Pachekenari A, Rahmani A, Ghahramanian A, Asghari Jafarabadi M, Onyeka TC, Davoodi A (2018) The effect of an oral care protocol and honey mouthwash on mucositis in acute myeloid leukemia patients undergoing chemotherapy: a single-blind clinical trial. Clin Oral Investig. https://doi.org/10.1007/s00784-018-2621-9 Khanjani Pour-Fard-Pachekenari A, Rahmani A, Ghahramanian A, Asghari Jafarabadi M, Onyeka TC, Davoodi A (2018) The effect of an oral care protocol and honey mouthwash on mucositis in acute myeloid leukemia patients undergoing chemotherapy: a single-blind clinical trial. Clin Oral Investig. https://​doi.​org/​10.​1007/​s00784-018-2621-9
20.
go back to reference Mishra L, Nayak G (2017) Effect of flavored (honey and tulsi) ice chips on reduction of Oral mucositis among children receiving chemotherapy. Int J Pharm Sci Rev Res 43(107):25–28 Mishra L, Nayak G (2017) Effect of flavored (honey and tulsi) ice chips on reduction of Oral mucositis among children receiving chemotherapy. Int J Pharm Sci Rev Res 43(107):25–28
22.
go back to reference Raeessi MA, Raeessi N, Panahi Y, Gharaie H, Davoudi SM, Saadat A, Karimi Zarchi AA, Raeessi F, Ahmadi SM, Jalalian H (2014) “Coffee plus honey” versus “topical steroid” in the treatment of chemotherapy-induced oral mucositis: a randomised controlled trial. BMC Complement Altern Med 14(293). https://doi.org/10.1186/1472-6882-14-293 Raeessi MA, Raeessi N, Panahi Y, Gharaie H, Davoudi SM, Saadat A, Karimi Zarchi AA, Raeessi F, Ahmadi SM, Jalalian H (2014) “Coffee plus honey” versus “topical steroid” in the treatment of chemotherapy-induced oral mucositis: a randomised controlled trial. BMC Complement Altern Med 14(293). https://​doi.​org/​10.​1186/​1472-6882-14-293
Metadata
Title
Prophylactic and therapeutic effects of honey on radiochemotherapy-induced mucositis: a meta-analysis of randomized controlled trials
Authors
Tzu-Ming Liu
Yu-Wei Luo
Ka-Wai Tam
Chia-Chin Lin
Tsai-Wei Huang
Publication date
01-07-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 7/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04722-3

Other articles of this Issue 7/2019

Supportive Care in Cancer 7/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine